Advertisement
Advertisement

SVRA

SVRA logo

Savara Inc.

5.83
USD
Sponsored
+0.04
+0.69%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

5.75

-0.08
-1.36%

Savara Inc. Profile

About

Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.

Info & Links

CEO

Matthew Pauls

Headquarters

1717 LANGHORE NEWTOWN ROAD, SUITE 300
LANGHORNE, PA 19047, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.savarapharma.com

Auditor

RSM US LLP

Share holders

86

Employees

70

Savara Inc. Statistics

Valuation Measures

Market Capitalization2

1.18B

Enterprise Value

1.17B

Enterprise Value/EBITDA(ttm)

-8.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.79

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-87.19%

Return on Invested Capital(ttm)

-75.98%

Return on Assets(ttm)

-66.42%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-135.60M

Net Income Available to Common(ttm)

-129.48M

Diluted EPS(ttm)

-0.56

Share Statistics

Beta (5Y Monthly)

0.29

52-Week Change

121.67%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

204.93M

Dividend Yield

0.00%

Float4

194.07M

% Held by Insiders

5.30%

% Held by Institutions

87.93%

Balance Sheet

Total Cash(mrq)

202.77M

Total Cash Per Share(mrq)

0.99

Total Debt(mrq)

30.07M

Total Debt/Equity(mrq)

17.08%

Current Ratio(mrq)

13.47%

Quick Ratio(mrq)

13.47%

Book Value Per Share(mrq)

0.86

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.13

Free Cash Flow(ytd)

-33.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement